Shinpoong Pharmaceutical Co.,Ltd

₩7,930As of Sun 8 Nov 2026, 12:00 UTC
KRX:019170Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 2.68%
Div yield —
ROE (0.28%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.04
PE TTM —
TSR TTM (41.48%)
Mkt cap ₩434.6B
ROIC (134.33%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩9,605
21.12%
(74.70%)
Hold 3|5|6|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
108.90
118.23
123.60
125.16
25.69%
38.91%
32.58%
24.49%
Revenue₩B
34.87
34.79
34.24
33.83
6.87%
3.19%
(0.43%)
(3.75%)
Peers (US$320.4M)
Cap (US$)
PE
380.5M
5.484x
Capital
TTM
5Y
10Y
Leveragex
1.422
(0.113)
(0.109)
EBIT/Intx
2.021
0.131
0.143
Own earn%
21.71
(28.90)
(49.53)
Sh yield%
50.92
16.38
14.57
Owners
Insiders/Inst%
9.94
31.22
Short interest%
3.78
SBC / revenue%
1.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
13–19
$1 testx
−0.1
Incr. ROIC%
8